Annovis Bio, Inc.

For the period ended Mar 31, 2025. Filed May 13, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 13, 2025

ANVS$0.90+6.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

QUARTERLY REPORT ON FORM 10-Q

FOR THE QUARTER ENDED MARCH 31, 2025

PART I – FINANCIAL INFORMATION	Page


Item 1.	Financial Statements	3

	Balance Sheets as of March 31, 2025 (Unaudited) and December 31, 2024	3

	Statements of Operations (Unaudited) for the Three Months Ended March 31, 2025 and 2024	4

	Statements of Changes in Stockholders’ (Deficit) Equity (Unaudited) for the Three Months Ended March 31, 2025 and 2024	5

	Statements of Cash Flows (Unaudited) for the Three Months Ended March 31, 2025 and 2024	6

	Notes to Financial Statements (Unaudited)	7

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	19

Item 3.	Quantitative and Qualitative Disclosure About Market Risk	25

Item 4.	Controls and Procedures	25


PART II – OTHER INFORMATION


Item 1.	Legal Proceedings	26

Item 1A.	Risk Factors	26

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	26

Item 3.	Defaults Upon Senior Securities	26

Item 4.	Mine Safety Disclosures	26

Item 5.	Other Information	26

Item 6.	Exhibits	27

	Signatures	28

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.

About this filing

Table of Contents